Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis
The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
This review has summarized some of the evidence suggesting that cytokines may play an important role in mediating pathophysiologic events in RA. However, these proteins are capable of mediating both stimulatory (agonist) and inhibitory (antagonist) effects in the rheumatoid synovium. GM-CSF, IL-1, TNF alpha, and PDGF are all produced in the rheumatoid synovium and may function to induce inflammation, enzyme release, fibroblast proliferation, and tissue destruction. Local release of IL-6 may alter the effects of IL-1 and TNF alpha, as well as induce Ig production and hepatic synthesis of acute-phase proteins. However, specific inhibitors of IL-1 and TNF alpha exist, which, if also released into the synovium, may antagonize the proinflammatory effects of these cytokines. In addition, IL-1 may have antiinflammatory effects, such as the induction of the synthesis of collagen and enzyme inhibitors by chondrocytes and synovial fibroblasts. Stimulation of these latter cells by TGF beta also may result in decreased matrix degradation and increased formation of scar tissue. The developing scenario is one of cell-cell interactions that are influenced in positive and negative manners by the local release of various mediators. A further understanding of cytokines and cytokine inhibitors in the rheumatoid synovium may lead to the development of more specific and effective therapeutic agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Some recent advances in the chemistry and biology of transforming growth factor-beta.
Sporn, M. B., Roberts, A. B., Wakefield, L. M., & de Crombrugghe, B. (1987) · The Journal of cell biology · doi:10.1083/jcb.105.3.1039 · Cited by 1,279
Dayer, J. M., Beutler, B., & Cerami, A. (1985) · The Journal of experimental medicine · doi:10.1084/jem.162.6.2163 · Cited by 1,216
Self-citationInterleukin-1 and Its Biologically Related Cytokines
Dinarello, C. A. (1989) · Advances in Immunology · doi:10.1016/s0065-2776(08)60642-2 · Cited by 1,151
BRENNAN, F. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90430-3 · Cited by 1,129
Houssiau, F. A., Devogelaer, J., Damme, J. V., Deuxchaisnes, C. N. D., & Snick, J. V. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310614 · Cited by 847
Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis
Hirano, T., Matsuda, T., Turner, M., Miyasaka, N., Buchan, G., Tang, B., Sato, K., Shimi, M., Maid, R., Feldmann, M., et al. (1988) · European Journal of Immunology · doi:10.1002/eji.1830181122 · Cited by 784
Interleukin-1 Mitogenic Activity for Fibroblasts and Smooth Muscle Cells Is Due to PDGF-AA
Raines, E. W., Dower, S. K., & Ross, R. (1989) · Science · doi:10.1126/science.2783498 · Cited by 646
Dayer, J. M., de Rochemonteix, B., Burrus, B., Demczuk, S., & Dinarello, C. A. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112350 · Cited by 624
Self-citationQuantitative analysis of cytokine gene expression in rheumatoid arthritis.
Firestein, G. S., Alvaro-Gracia, J. M., & Maki, R. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.9.3347 · Cited by 598
Saxne, T., Palladino, M. A., Heinegãrd, D., Talal, N., & Wollheim, F. A. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310816 · Cited by 566
Multiple actions of interleukin 6 within a cytokine network
Wong, G. G., & Clark, S. C. (1988) · Immunology Today · doi:10.1016/0167-5699(88)91200-5 · Cited by 529
Guerne, P. A., Zuraw, B. L., Vaughan, J. H., Carson, D. A., & Lotz, M. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113921 · Cited by 513
Pettipher, E. R., Higgs, G. A., & Henderson, B. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.22.8749 · Cited by 496
CORRELATION OF PLASMA INTERLEUKIN 1 LEVELS WITH DISEASE ACTIVITY IN RHEUMATOID ARTHRITIS
Eastgate, J., Wood, N., Di Giovine, F., Symons, J., Grinlinton, F., & Duff, G. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90185-7 · Cited by 484
Engelmann, H., Aderka, D., Rubinstein, M., Rotman, D., & Wallach, D. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)80162-4 · Cited by 440
Soluble cytokine receptors are present in normal human urine.
Novick, D., Engelmann, H., Wallach, D., & Rubinstein, M. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.4.1409 · Cited by 434
Sherry, B., & Cerami, A. (1988) · The Journal of cell biology · doi:10.1083/jcb.107.4.1269 · Cited by 432
Goldring, M. B., Birkhead, J., Sandell, L. J., Kimura, T., & Krane, S. M. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113823 · Cited by 397
Buchan, G. S., Barrett, K., Turner, M., Chantry, D., Maini, R. N., & Feldmann, M. (1988) · PubMed Central · Cited by 385
A urine inhibitor of interleukin 1 activity that blocks ligand binding.
Seckinger, P., Lowenthal, J. W., Williamson, K., Dayer, J. M., & MacDonald, H. R. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.5.1546 · Cited by 345
Self-citationLafyatis, R., Remmers, E. F., Roberts, A. B., Yocum, D. E., Sporn, M. B., & Wilder, R. L. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114011 · Cited by 323
Arend, W. P., Joslin, F. G., & Massoni, R. J. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.134.6.3868 · Cited by 322
Self-citationCzarniecki, C. W., Chiu, H. H., Wong, G. H. W., McCabe, S. M., & Palladino, M. A. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.140.12.4217 · Cited by 294
Purification and biologic characterization of a specific tumor necrosis factor α inhibitor
Seckinger, P., Isaaz, S., & Dayer, J. M. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)80161-2 · Cited by 291
Self-citationActive and latent forms of transforming growth factor beta activity in synovial effusions.
Fava, R., Olsen, N., Keski-Oja, J., Moses, H., & Pincus, T. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.1.291 · Cited by 261
Xu, W. D., Firestein, G. S., Taetle, R., Kaushansky, K., & Zvaifler, N. J. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113971 · Cited by 258
A human inhibitor of tumor necrosis factor alpha.
Seckinger, P., Isaaz, S., & Dayer, J. M. (1988) · The Journal of experimental medicine · doi:10.1084/jem.167.4.1511 · Cited by 255
Self-citationPostlethwaite, A., Raghow, R., Stricklin, G., Poppleton, H., Seyer, J., & Kang, A. (1988) · The Journal of cell biology · doi:10.1083/jcb.106.2.311 · Cited by 251
Firestein, G. S., Xu, W. D., Townsend, K., Broide, D., Alvaro-Gracia, J., Glasebrook, A., & Zvaifler, N. J. (1988) · The Journal of experimental medicine · doi:10.1084/jem.168.5.1573 · Cited by 247
Isolation and characterization of a tumor necrosis factor binding protein from urine
Olsson, I., Lantz, M., Nilsson, E., Peetre, C., Thysell, H., Grubb, A., & Adolf, G. (1989) · European Journal of Haematology · doi:10.1111/j.1600-0609.1989.tb00111.x · Cited by 245
Henderson, B. E., & Pettipher, E. R. (1989) · PubMed Central · Cited by 245
The role of interleukin-17 in the pathogenesis of rheumatoid arthritis
Gaffen, S. L. (2009) · Current Rheumatology Reports · doi:10.1007/s11926-009-0052-y · Cited by 235
Cytokines in synovial fluid: II. The presence of tumour necrosis factor and interferon.
Hopkins, S. J., & Meager, A. (1988) · PubMed Central · Cited by 216
An IL-1 inhibitor from human monocytes. Production and characterization of biologic properties.
Arend, W. P., Joslin, F. G., Thompson, R. C., & Hannum, C. H. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.6.1851 · Cited by 206
Self-citationBalavoine, J. F., de Rochemonteix, B., Williamson, K., Seckinger, P., Cruchaud, A., & Dayer, J. M. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112669 · Cited by 205
Self-citationSensitization and desensitization to lethal effects of tumor necrosis factor and IL-1.
Wallach, D., Holtmann, H., Engelmann, H., & Nophar, Y. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.140.9.2994 · Cited by 175
Firestein, G. S., & Zvaifler, N. J. (1987) · Arthritis & Rheumatism · doi:10.1002/art.1780300804 · Cited by 175
Native interleukin 1 inhibitors
Larrick, J. W. (1989) · Immunology Today · doi:10.1016/0167-5699(89)90308-3 · Cited by 163
Krane, S. M., Dayer, J.-M., Simon, L. S., & Byrne, M. S. (1985) · Collagen and Related Research · doi:10.1016/s0174-173x(85)80033-9 · Cited by 163
Self-citationAlvaro-Gracia, J. M., Zvaifler, N. J., & Firestein, G. S. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.3.865 · Cited by 162
In vivo administration with IL-1 accelerates the development of collagen-induced arthritis in mice.
Hom, J. T., Bendele, A. M., & Carlson, D. G. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.141.3.834 · Cited by 154
Seckinger, P., Williamson, K., Balavoine, J. F., Mach, B., Mazzei, G., Shaw, A., & Dayer, J. M. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.5.1541 · Cited by 140
Self-citationPrieur, A., Griscelli, C., Kaufmann, M., & Dayer, J. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91854-x · Cited by 122
Self-citationSynovial localization of tumor necrosis factor in patients with rheumatoid arthritis
Husby, G., & Williams, R. C. (1988) · Journal of Autoimmunity · doi:10.1016/0896-8411(88)90006-6 · Cited by 116
Bhardwaj, N., Santhanam, U., Lau, L. L., Tatter, S. B., Ghrayeb, J., Rivelis, M., Steinman, R. M., Sehgal, P. B., & May, L. T. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.7.2153 · Cited by 114
Characteristics of tumor necrosis factor production in rheumatoid arthritis
Yocum, D. E., Esparza, L., Dubry, S., Benjamin, J. B., VOLZ, R. G., & Scuderi, P. (1989) · Cellular Immunology · doi:10.1016/0008-8749(89)90154-8 · Cited by 113
Roux-Lombard, P., Modoux, C., & Dayer, J. (1989) · Cytokine · doi:10.1016/1043-4666(89)91047-8 · Cited by 87
Self-citationShore, A., Jaglal, S. B., & Keystone, E. C. (1986) · PubMed · Cited by 76
The detection and initial characterization of colony-stimulating factors in synovial fluid.
Williamson, D. J., Begley, C. G., Vadas, M. A., & Metcalf, D. (1988) · PubMed Central · Cited by 76
Yaron, I., Meyer, F. A., Dayer, J., Bleiberg, I., & Yaron, M. (1989) · Arthritis & Rheumatism · doi:10.1002/anr.1780320210 · Cited by 56
Self-citationConstitutive production of interleukin 6/B cell stimulatory factor-2 from inflammatory synovium
Miyasaka, N., Sato, K., Hashimoto, J., Kohsaka, H., Yamamoto, K., Goto, M., Inoue, K., Matsuda, T., Hirano, T., Kishimoto, T., et al. (1989) · Clinical Immunology and Immunopathology · doi:10.1016/0090-1229(89)90175-x · Cited by 53
Butler, D., Leizer, T., & Hamilton, J. A. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.142.9.3098 · Cited by 47
Interleukin-1 production by mononuclear cells from rheumatoid synovial effusions
Bhardwaj, N., Lau, L. L., Rivelis, M., & Steinman, R. M. (1988) · Cellular Immunology · doi:10.1016/0008-8749(88)90332-2 · Cited by 41
Cited by
ROLE OF CYTOKINES IN RHEUMATOID ARTHRITIS
Feldmann, M., Brennan, F. M., & Maini, R. N. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.397 · Cited by 2,514
Tumor necrosis factor antagonist mechanisms of action: A comprehensive review
Tracey, D., Klareskog, L., Sasso, E. H., Salfeld, J. G., & Tak, P. P. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.10.001 · Cited by 1,628
Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis.
Williams, R. O., Feldmann, M., & Maini, R. N. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.20.9784 · Cited by 989
Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium
Chabaud, M., Durand, J. M., Buchs, N., Fossiez, F., Page, G., Frappart, L., & Miossec, P. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199905)42:5<963::aid-anr15>3.0.co;2-e · Cited by 954
Arend, W. P., & Dayer, J. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380202 · Cited by 891
Self-citation
Metadata
- Authors
- Arend, W. P., & Dayer, J.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 1990-03
- Volume
- 33
- Issue
- 3
- Pages
- 305-315
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2098015378
- Cited by
- 949
- References
- 53
- FWCI
- 46.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.